丙型肝炎治疗的研究进展

www.yongyao.net　　2009-8-31 13:43:06　　来源：　　责任编辑：

分享到：

综上所述,由于目前对丙型肝炎的治疗尚缺乏有效手段,因此发展治疗性疫苗对控制HCV感染极为重要。目前,很快研制出有效治疗HCV感染的疫苗并不现实。但随着对HCV蛋白和序列作用的不断认识及新研究靶点的不断出现,必将设计出包含有多个保守HCV抗原表位的多价融合抗原基因的DNA疫苗。该疫苗可以在人群的不同个体中激起广泛而强烈的对不同HCV基因型和分离株有交叉反应性的T细胞免疫应答,并有望应用于HCV感染人群的治疗。

参考文献
[ 1 ] 　Cohen J. The scientific challenge of hepatitis C[ J ]. Science, 1999,285 (5424) : 26230.
[ 2 ] 　凌世淦. 丙型肝炎疫苗研究的挑战与希望[ J ]. 中华微生物学和免疫学杂志, 2004, 24 (11) : 9212922.
[ 3 ] 　Modi AA, Liang TJ. Hepatitis C: a clinical review [ J ]. Oral Dis,2008, 14 (1) : 10214.
[ 4 ] 　Nakamura H,Uyama H, Enomoto H, et al. The combination therapy of interferon and amantadine hydrochloride for patientswith chronic hepatitis C[ J ]. Hepatogastroenterology, 2003, 50 (49) : 2222226.
[ 5 ] 　Tan SL, Pause A, Shi Y, et al. Hepatitis C therapeutics: current status and emerging strategies [ J ]. Nat Rev Drug Discov, 2002, 1(11) : 8672881.
[ 6 ] 　De Francesco R, Rice CM. New therap ies on the horizon for hepatitis C: are we close? [ J ]. Clin LiverDis, 2003, 7 (1) : 2112242.
[ 7 ] 　VolarevicM, Smolic R,Wu CH, et al. Potential role of RNAi in the treatment of HCV infection [ J ]. Expert Rev Anti Infect Ther,2007, 5 (5) : 8232831.
[ 8 ] 　Suzuki H, Kaneko H, TamaiN, et al. Supp ression of hepatitis C virus core p rotein by short hairp in RNA exp ression vectors in the core p rotein exp ression Huh27 cells [ J ]. Nucleosides Nucleotides Nucleic Acids, 2007, 26 (6 /7) : 8152820.
[ 9 ] 　McCaffrey AP,Meuse L, Pham TT, et al. RNA interference in adultmice[ J ]. Nature, 2002, 418 (6893) : 38239.
[ 10 ] 　雷迎峰,薛小平,尹文,等. RNAi对HCV NS5B 基因表达的抑制作用[ J ]. 第四军医大学学报, 2003, 24 (12) : 108221084.
[ 11 ] 　Tuschl T, Elbashir S, Harborth J, et al. The siRNA user guide[ EB /OL ]. http: / /www. Mp ibpc. gwdg. de / abteilungen /100 /105 / sirna. html, 2002211225 /2007210208.
[ 12 ] 　SeoMY, Abrignani S, Houghton M, et al. Small interfering RNA mediated inhibition of hepatitis C virus rep lication in the human heap toma cell line Huh7 [ J ]. J Virol, 2003, 77 (1) : 8102812.
[ 13 ] 　饶林,詹林盛,彭剑淳,等. siRNA 抑制丙型肝炎病毒IRES介导的基因表达[ J ]. 中国生物化学与分子生物学报, 2004, 20(1) : 38243.
[ 14 ] 　Welbourn S, Pause A. The hepatitis C virus NS2 /3 p rotease [ J ].Curr IssuesMol Biol, 2007, 9 (1) : 63269.
[ 15 ] 　De Francesco R, CarfíA. Advances in the development of new therapeutic agents targeting the NS324A serine p rotease or the NS5BRNA2dependent RNA polymerase of the hepatitis C virus[ J ]. Adv
Drug Deliv Rev, 2007, 59 (12) : 124221262.
[ 16 ] 　邓涛,陈乃玲,陈天宝,等. 丙肝病毒(HCV)基因免疫实验研究[ J ]. 中国免疫学杂志, 1999, 15 (11) : 4942496.
[ 17 ] 　赵连三,周陶友,秦山,等. 丙型肝炎病毒核酸疫苗NV2HC /NS3的免疫预防和治疗效应研究[ J ]. 中华肝脏病杂志, 2001, 9(4) : 2032205.
[ 18 ] 　周永兴,贾战生. 进一步加强病毒性肝炎基因治疗的研究[ J ].第四军医大学学报, 2000, (7) : 7812783.
[ 19 ] 　王小红,王升启,李梦东,等. 反义寡核苷酸对丙型肝炎病毒调控基因表达的体外抑制活性研究[ J ]. 病毒学报, 1999, 15 ( 3) :2242230.
[ 20 ] 　Witherell G. ISIS214803 ( Isis Pharmaceuticals) [ J ]. Curr Op in InzestDrugs, 2001, 2 (11) : 152321529.
[ 21 ] 　Urabni S,Uggeri J,Matsuura Y, et al. Identification of immnodominant hepatitis C virus (HCV) specific cytotoxic T2cell ep itopes by stimulation with endogenously synthesized HCV antigens[ J ]. Hepatology, 2001, 33 (6) : 153321543.
[ 22 ] 　Frelin L,AlheimM, Chen A, et al. Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA2based vaccine containingNS4A inhibitNS3 /4A exp ressing tumors in vivo
[ J ]. Gene Ther, 2003, 10 (8) : 6862699.
[ 23 ] 　王子来,陈丽珊,李琦涵,等. HCV多表位抗原基因的表达及其在小鼠中诱导的抗体应答研究[ J ]. 复旦学报(自然科学版) ,2004, 43 (2) : 1632168.
[ 24 ] 　陈佳玉,李凡. 乙型肝炎核心抗原为载体进行丙型肝炎混合性治疗疫苗的实验研究[ J ]. 中华传染病杂志, 2007, 25 ( 3 ) :1372142.